NCT02914379View on ClinicalTrials.gov

A Study of LY3337641 in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Healthy
Interventions
DRUG

[¹⁴C]-LY3337641

Administered orally

Trial Locations (1)

53704

Covance Clinical Research Unit, Madison

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02914379 - A Study of LY3337641 in Healthy Male Participants | Biotech Hunter | Biotech Hunter